Data search
Results for MligTC455_19890
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_19890 | 2301 | 47.93 | Mlig455_070929 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.310 Region-enriched R2: 1.219/0.03494 |
GAPDHS | Mlig455_070929 {REF} {Length: 1437} {TRANSSPLICED} {Pfam: Glyceraldehyde 3-phosphate dehydrogenase, C-terminal domain [PF02800.22, score=143.6]; Glyceraldehyde 3-phosphate dehydrogenase, NAD binding domain [PF00044.26, score=90.4]} {Human: ENSG00000105679, GAPDHS, glyceraldehyde-3-phosphate dehydrogenase, spermatogenic, [Score=378, Expect=1e-130]; ENSG00000111640, GAPDH, glyceraldehyde-3-phosphate dehydrogenase, [Score=377, Expect=2e-131]} {Mouse: ENSMUSG00000057666, Gapdh, glyceraldehyde-3-phosphate dehydrogenase, [Score=384, Expect=3e-134]; ENSMUSG00000110469, Gm10358, predicted gene 10358, [Score=383, Expect=4e-134]; ENSMUSG00000097148, Gm3839, predicted pseudogene 3839, [Score=383, Expect=6e-134]; ENSMUSG00000061099, Gapdhs, glyceraldehyde-3-phosphate dehydrogenase, spermatogenic, [Score=367, Expect=2e-126]} {Dmel: FBgn0001092, Gapdh2, Glyceraldehyde 3 phosphate dehydrogenase 2, [Score=377, Expect=1e-131]} {Celegans: WBGene00001685, gpd-3, Glyceraldehyde-3-phosphate dehydrogenase 3, [Score=376, Expect=3e-131]} {Smed: dd_Smed_v6_78_0_1, dd_Smed_v6_78_0_1, [Score=407, Expect=9e-144]} {RNA1509_14226} {RNA1310_20591} {RNA815_8300.1} |
Cumulative graph for MligTC455_19890
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 0.315 | 5.744 | 0.62115 | 1.00000 | |
| RegionR2 | 1.219 | 5.744 | 0.00200 | 0.03494 | |
| RegionR3 | -0.086 | 5.744 | 0.81211 | 1.00000 | |
| RegionR4 | 1.07 | 5.744 | 0.00852 | 0.05412 | |
| RegionR5 | -1.639 | 5.744 | 0.00003 | 0.00059 | |
| RegionR6 | -0.308 | 5.744 | 0.41243 | 0.98118 | |
| RegionR7 | -0.281 | 5.744 | 0.48076 | 1.00000 | |
| RegionR8 | -0.289 | 5.744 | 0.53277 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -1.934 | 5.744 | 0.04281 | 0.67581 | |
| RegenerationR2 | -1.307 | 5.744 | 0.00344 | 0.08994 | |
| RegenerationR3 | -0.733 | 5.744 | 0.11108 | 0.52459 | |
| RegenerationR4 | -1.395 | 5.744 | 0.00374 | 0.08361 | |
| RegenerationR5 | -0.257 | 5.744 | 0.59046 | 0.90586 | |
| RegenerationR6 | -1.101 | 5.744 | 0.02134 | 0.18107 | |
| RegenerationBL | -0.941 | 5.744 | 0.04708 | 0.24833 | |
| RegenerationTP | -0.7 | 5.744 | 0.15460 | 0.58155 |
Genes with expression patterns similar to MligTC455_19890
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_19890 | 2301 | 47.93 | Mlig455_070929 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.310 Region-enriched R2: 1.219/0.03494 |
GAPDHS | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_070929 {REF} {Length: 1437} {TRANSSPLICED} {Pfam: Glyceraldehyde 3-phosphate dehydrogenase, C-terminal domain [PF02800.22, score=143.6]; Glyceraldehyde 3-phosphate dehydrogenase, NAD binding domain [PF00044.26, score=90.4]} {Human: ENSG00000105679, GAPDHS, glyceraldehyde-3-phosphate dehydrogenase, spermatogenic, [Score=378, Expect=1e-130]; ENSG00000111640, GAPDH, glyceraldehyde-3-phosphate dehydrogenase, [Score=377, Expect=2e-131]} {Mouse: ENSMUSG00000057666, Gapdh, glyceraldehyde-3-phosphate dehydrogenase, [Score=384, Expect=3e-134]; ENSMUSG00000110469, Gm10358, predicted gene 10358, [Score=383, Expect=4e-134]; ENSMUSG00000097148, Gm3839, predicted pseudogene 3839, [Score=383, Expect=6e-134]; ENSMUSG00000061099, Gapdhs, glyceraldehyde-3-phosphate dehydrogenase, spermatogenic, [Score=367, Expect=2e-126]} {Dmel: FBgn0001092, Gapdh2, Glyceraldehyde 3 phosphate dehydrogenase 2, [Score=377, Expect=1e-131]} {Celegans: WBGene00001685, gpd-3, Glyceraldehyde-3-phosphate dehydrogenase 3, [Score=376, Expect=3e-131]} {Smed: dd_Smed_v6_78_0_1, dd_Smed_v6_78_0_1, [Score=407, Expect=9e-144]} {RNA1509_14226} {RNA1310_20591} {RNA815_8300.1} |
| 2. | MligTC455_19889 | 2061 | 42.94 | Mlig455_009500 | Neo: - Age: Up-Down-Down Region-enriched R4: 1.226/0.02420 |
GAPDH | 4.829 | - | 0.934 | 0.938 | 0.969 | 0.990 | 0.998 | Mlig455_009500 {REF} {Length: 1545} {TRANSSPLICED} {Pfam: Glyceraldehyde 3-phosphate dehydrogenase, C-terminal domain [PF02800.22, score=234.0]; Glyceraldehyde 3-phosphate dehydrogenase, NAD binding domain [PF00044.26, score=130.7]} {Human: ENSG00000111640, GAPDH, glyceraldehyde-3-phosphate dehydrogenase, [RH, Score=506, Expect=0.0]; ENSG00000105679, GAPDHS, glyceraldehyde-3-phosphate dehydrogenase, spermatogenic, [RH, Score=497, Expect=5e-177]} {Mouse: ENSMUSG00000057666, Gapdh, glyceraldehyde-3-phosphate dehydrogenase, [RH, Score=514, Expect=0.0]; ENSMUSG00000110469, Gm10358, predicted gene 10358, [RH, Score=512, Expect=0.0]; ENSMUSG00000097148, Gm3839, predicted pseudogene 3839, [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001092, Gapdh2, Glyceraldehyde 3 phosphate dehydrogenase 2, [RH, Score=496, Expect=6e-178]} {Celegans: WBGene00001685, gpd-3, Glyceraldehyde-3-phosphate dehydrogenase 3, [RH, Score=507, Expect=0.0]} {Smed: dd_Smed_v6_78_0_1, dd_Smed_v6_78_0_1, [RH, Score=518, Expect=0.0]} {RNA1509_11046, RNA1509_11538, RNA1509_2151, RNA1509_40411, RNA1509_55377, RNA1509_58362, RNA1509_59045} {RNA1310_20591, RNA1509_11046, RNA1509_11538, RNA1509_2151, RNA1509_40411, RNA1509_55377, RNA1509_58362, RNA1509_59045} {RNA1509_11046, RNA1509_11538, RNA1509_2151, RNA1509_40411, RNA1509_55377, RNA1509_58362, RNA1509_59045, RNA815_8300.1} |
| 3. | MligTC455_22037 | 397 | 8.28 | Mlig455_013950, Mlig455_039339 | Neo: Germline Age: - Region-enriched R4: 2.424/0.00629 |
DRD2 | 2.599 | - | - | - | 0.859 | 0.966 | 0.774 | Mlig455_013950 {REF} {Length: 2458} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=247.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=49.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=33.6]; Olfactory receptor [PF13853.8, score=24.0]} {Human: ENSG00000149295, DRD2, dopamine receptor D2, [Score=242, Expect=9e-74]} {Mouse: ENSMUSG00000032259, Drd2, dopamine receptor D2, [Score=235, Expect=2e-71]; ENSMUSG00000022705, Drd3, dopamine receptor D3, [Score=231, Expect=2e-69]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=330, Expect=6e-104]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=199, Expect=1e-57]} {Smed: dd_Smed_v6_27884_0_1, dd_Smed_v6_27884_0_1, [Score=281, Expect=9e-89]} {RNA1509_30039} {RNA1310_24944} {RNA815_15995} Mlig455_039339 {REF} {Length: 4177} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=70.7]} {Human: ENSG00000149295, DRD2, dopamine receptor D2, [Score=100, Expect=5e-25]; ENSG00000179546, HTR1D, 5-hydroxytryptamine receptor 1D, [Score=96.7, Expect=1e-23]} {Mouse: ENSMUSG00000032259, Drd2, dopamine receptor D2, [Score=99.8, Expect=1e-24]; ENSMUSG00000070687, Htr1d, 5-hydroxytryptamine (serotonin) receptor 1D, [Score=97.4, Expect=4e-24]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=116, Expect=1e-30]} {Celegans: WBGene00017157, tyra-2, Tyramine receptor tyra-2, [Score=88.2, Expect=3e-21]} {Smed: dd_Smed_v6_36844_0_1, dd_Smed_v6_36844_0_1, [Score=109, Expect=2e-29]} {RNA1509_30039} {RNA1310_24944} {RNA815_15995} |
| 4. | MligTC455_43621 | 222 | 4.63 | Mlig455_025703 | Neo: - Age: - Region-enriched R4: 4.147/0.00000 |
2.39 | - | 0.702 | - | 0.723 | 0.965 | - | Mlig455_025703 {REF} {Length: 2480} {RNA1509_50338} {RNA1310_25031} {RNA815_24211} | |
| 5. | MligTC455_49862 | 26 | 0.54 | Mlig455_019435 | Neo: - Age: - |
SHOX2 | 1.773 | - | - | - | 0.823 | 0.950 | - | Mlig455_019435 {REF} {Length: 904} {Pfam: Homeodomain [PF00046.31, score=84.8]; Homeobox KN domain [PF05920.13, score=23.6]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=89.0, Expect=4e-22]; ENSG00000185960, SHOX, short stature homeobox, [Score=87.0, Expect=5e-21]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=89.0, Expect=3e-22]} {Dmel: FBgn0085396, CG34367, [Score=89.7, Expect=9e-22]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=83.6, Expect=5e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=86.3, Expect=2e-20]} {RNA1310_51707} {RNA815_41055} |
| 6. | MligTC455_05879 | 15 | 0.32 | Mlig455_063605 | Neo: - Age: - |
1.719 | - | - | - | 0.765 | 0.954 | - | Mlig455_063605 {REF} {Length: 563} {NoTransDecoderORF} {RNA1509_52081} {RNA1310_66924} {RNA815_45160} | |
| 7. | MligTC455_13450 | 29 | 0.6 | Mlig455_067206 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_067206 {REF} {Length: 4119} {NoTransDecoderORF} {RNA1509_56630} {RNA1310_26826} {RNA815_17301.1} | |
| 8. | MligTC455_25424 | 101 | 2.1 | Mlig455_048338 | Neo: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_048338 {REF} {Length: 2137} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=53.2]} {Smed: dd_Smed_v6_13661_0_2, dd_Smed_v6_13661_0_2, [Score=108, Expect=2e-29]} {RNA1509_28167} {RNA1310_10604.1} {RNA815_5663} | |
| 9. | MligTC455_00401 | 18 | 0.37 | Mlig455_066572 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_066572 {REF} {Length: 123} {NoTransDecoderORF} {RNA1310_85631} | |
| 10. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
Berezikov Lab - 2020-2021 © ERIBA